Reinventing Flexion For The World Beyond Proof-Of-Concept

Flexion Therapeutics had the pedigree, determination, and corporate connections to source and speed to clinical proof-of-concept its in-licensed pharma assets, and it planned to build a business around getting paid to do so. But a funny thing happened on the way to the bank.

If you build it, they will come. And if you can build it faster and cheaper, well, the pharmaceutical world will beat a path to your laboratory door, pay you handsomely for your efforts, and everyone walks away happy.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business Strategy

More from In Vivo